ArticleJournal of medicinal chemistry2022

Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent.

Yutian Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.